Skip to content

Study · Measured the body's own peptide · 1996

1 result

Immunoreactivity of central vasopressin and oxytocin pathways in microtine rodents: a quantitative comparative study.

Wang Z, Zhou L, Hulihan TJ, Insel TR

The Journal of comparative neurology1 Mar 1996Cited by 131 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In four Microtus vole species, species differences in oxytocin staining were subtle relative to the previously reported species differences in receptor binding.

    In plain wordsIn voles, natural oxytocin staining in the brain differed only slightly between species, much less than receptor binding differences reported earlier.

    Peptide
    Oxytocin
    Outcome
    Not applicableSpecies differences in oxytocin immunoreactivity
    Study

    vole (Microtus)n: not reported in source

    two monogamous and two nonmonogamous Microtus species
    Outcome group
    Endogenous peptide levels · Nervous system and cognition

    Source sentences

    Summary
    Also, species differences in oxytocin and vasopressin staining were subtle relative to the profound species differences previously reported for receptor binding.
    1 context sentence
    Summary · context
    In the current study, two monogamous and two nonmonogamous vole species were compared for the distribution of oxytocin and vasopressin immunoreactivity.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.